FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Broadrick Dale 2. Issuer Name and Ticker or Trading Symbol BioRestorative Therapies, Inc. [ BRTX ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)         (First)         (Middle)
3003 BRICK CHURCH PIKE
3. Date of Earliest Transaction (MM/DD/YYYY)
4/4/2019
(Street)
NASHVILLE, TN 37207
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  4/4/2019    P    2500  A $.8  2500  I  See footnote (1)
Common Stock  11/15/2019    P    10000  A $.074  7834445  D   
Common Stock  11/21/2019    P    80000  A $.049  7914445  D   
Common Stock  11/21/2019    P    58000  A $.05  7972445  D   
Common Stock  12/4/2019    P    92351  A $.0295  8064796  D   
Common Stock  12/4/2019    P    200000  A $.03  8264796  D   
Common Stock  12/5/2019    P    7649  A $.029  8272445  D   
Common Stock  12/5/2019    P    223030  A $.025  8495475  D   
Common Stock  12/5/2019    P    20000  A $.028  22500  I  See footnote (1)
Common Stock  12/6/2019    P    304237  A $.025  8799712  D   
Common Stock  12/6/2019    P    1010085  A $.0321 (2) 1032585  I  See footnote (1)
Common Stock  12/9/2019    P    81000  A $.036  1113585  I  See footnote (1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant to acquire Common Stock  $.15  12/6/2019    J        500000   2/19/2019  2/19/2024  Common Stock  500000   (3) 0  D   
Warrant to acquire Common Stock  $.03  12/6/2019    J     500000      2/19/2019  2/19/2024  Common Stock  500000   (3) 500000  D   
Warrant to acquire Common Stock  $.15  12/6/2019    J        500000   2/19/2019  2/19/2024  Common Stock  500000   (3) 0  D   
Warrant to acquire Common Stock  $.03  12/6/2019    J     500000      2/19/2019  2/19/2024  Common Stock  500000   (3) 500000  D   
Warrant to acquire Common Stock  $.15  12/6/2019    J        555556   5/7/2019  5/7/2024  Common Stock  555556   (3) 0  D   
Warrant to acquire Common Stock  $.03  12/6/2019    J     555556      5/7/2019  5/7/2024  Common Stock  555556   (3) 555556  D   
Warrant to acquire Common Stock  $.15  12/6/2019    J        555555   5/7/2019  5/7/2024  Common Stock  555555   (3) 0  D   
Warrant to acquire Common Stock  $.03  12/6/2019    J     555555      5/7/2019  5/7/2024  Common Stock  555555   (3) 555555  D   
Warrant to acquire Common Stock  $.2  12/6/2019    J        3333333   10/16/2019  10/16/2024  Common Stock  3333333   (3) 0  D   
Warrant to acquire Common Stock  $.03  12/6/2019    J     3333333      10/16/2019  10/16/2024  Common Stock  3333333   (3) 3333333  D   

Explanation of Responses:
(1)  Owned by Fleetco, Inc. of which reporting person is sole shareholder.
(2)  This transaction was executed in multiple trades at prices ranging from $.0279 to $.04 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
(3)  The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Broadrick Dale
3003 BRICK CHURCH PIKE
NASHVILLE, TN 37207

X


Signatures
/s/ Dale Broadrick 12/9/2019
**Signature of Reporting Person Date
BioRestorative Therapies (PK) (USOTC:BRTX)
Historical Stock Chart
From Dec 2020 to Jan 2021 Click Here for more BioRestorative Therapies (PK) Charts.
BioRestorative Therapies (PK) (USOTC:BRTX)
Historical Stock Chart
From Jan 2020 to Jan 2021 Click Here for more BioRestorative Therapies (PK) Charts.